The Trump administration is set to weigh in on whether the hallucinogenic compound psilocybin should be moved into a less restrictive class of drugs under federal regulations. Regulation of psilocybin ...
Forbes contributors publish independent expert analyses and insights. James Broughel is an economist focused on the economics of regulation. The Washington Post recently revealed that the Department ...
Six weeks after a reduction in force (RIF) at the US Food and Drug Administration removed thousands of workers, signs are emerging about how the agency’s approach to drug approval may change. The 20% ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Section 1. Purpose. The United States is drastically overregulated. The Code of Federal Regulations contains over 48,000 sections, stretching over 175,000 pages — far more than any citizen can ...
President Trump’s AI Action Plan released on July 23 again demonstrates the US government will both avoid onerous AI regulation and try to knock out disruptive US state laws. Though Congress failed in ...
Anjana Susarla does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
The Supreme Court on Monday agreed to consider the constitutionality of the federal ban on gun possession by illegal drug users. The Trump administration is urging the justices to overturn a ruling in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results